
Regeneron Pharmaceuticals, Inc.
REGNHealthcare|Biotechnology|US
$904.35
+1.45 (+0.16%)
DCF Value
$2028.80
Tangible Book / Share
$316.45
Graham Number
$592.50
Cash / Share
$91.46
Ownership Breakdown
96.2%
Float
103.4M
Shares Outstanding
99.6M
Float Shares
Major Holders (4)
Combined: 18.2%
Holders of 5%+ from their latest Schedule 13D/13G filing in the last two years. Percentages are as of each filing date.
Insider Trades (100)
Last 4 quarters: 119,623 acquired · 199,059 disposed
| Insider | Position | Date | Type | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|---|
| Pitofsky Jason | SVP Controller | Nov 4, 2026 | OPTION EX. | 905 | $492.00 | $445.3K | Form 4 |
| Pitofsky Jason | SVP Controller | Nov 4, 2026 | SELL | 439 | $939.57 | $412.5K | Form 4 |
| Pitofsky Jason | SVP Controller | Nov 4, 2026 | OPTION EX. | 1,478 | $644.54 | $952.6K | Form 4 |
| Pitofsky Jason | SVP Controller | Nov 4, 2026 | SELL | 575 | $940.46 | $540.8K | Form 4 |
| Pitofsky Jason | SVP Controller | Nov 4, 2026 | SELL | 982 | $941.58 | $924.6K | Form 4 |
| Pitofsky Jason | SVP Controller | Nov 4, 2026 | OPTION EX. | 1,500 | $726.53 | $1.1M | Form 4 |
| Pitofsky Jason | SVP Controller | Nov 4, 2026 | SELL | 1,215 | $942.31 | $1.1M | Form 4 |
| Pitofsky Jason | SVP Controller | Nov 4, 2026 | SELL | 529 | $943.53 | $499.1K | Form 4 |
| Pitofsky Jason | SVP Controller | Nov 4, 2026 | SELL | 108 | $944.22 | $102.0K | Form 4 |
| Pitofsky Jason | SVP Controller | Nov 4, 2026 | SELL | 35 | $945.61 | $33.1K | Form 4 |
| Pitofsky Jason | SVP Controller | Nov 4, 2026 | OPTION EX. | 1,500 | $726.53 | $1.1M | Form 4 |
| Pitofsky Jason | SVP Controller | Nov 4, 2026 | OPTION EX. | 1,478 | $644.54 | $952.6K | Form 4 |
| Pitofsky Jason | SVP Controller | Nov 4, 2026 | OPTION EX. | 905 | $492.00 | $445.3K | Form 4 |
| Pitofsky Jason | SVP Controller | Nov 4, 2026 | SELL | 179 | $950.76 | $170.2K | Form 4 |
| MURPHY ANDREW J | Co-Chief Scientific Officer | Nov 3, 2026 | GIFT | 1,054 | — | — | Form 4 |
| Zoghbi Huda Y | director | Nov 3, 2026 | OPTION EX. | 7,439 | $380.95 | $2.8M | Form 4 |
| Zoghbi Huda Y | director | Nov 3, 2026 | SELL | 6,939 | $970.42 | $6.7M | Form 4 |
| Zoghbi Huda Y | director | Nov 3, 2026 | SELL | 500 | $971.06 | $485.5K | Form 4 |
| Zoghbi Huda Y | director | Nov 3, 2026 | OPTION EX. | 7,439 | $380.95 | $2.8M | Form 4 |
| SING GEORGE L | director | Nov 2, 2026 | OPTION EX. | 7,439 | $380.95 | $2.8M | Form 4 |
| SING GEORGE L | director | Nov 2, 2026 | SELL | 1,224 | $960.57 | $1.2M | Form 4 |
| SING GEORGE L | director | Nov 2, 2026 | SELL | 540 | $961.85 | $519.4K | Form 4 |
| SING GEORGE L | director | Nov 2, 2026 | SELL | 2,522 | $962.61 | $2.4M | Form 4 |
| SING GEORGE L | director | Nov 2, 2026 | OPTION EX. | 7,830 | $376.69 | $2.9M | Form 4 |
| SING GEORGE L | director | Nov 2, 2026 | SELL | 4,338 | $963.47 | $4.2M | Form 4 |
| SING GEORGE L | director | Nov 2, 2026 | SELL | 2,670 | $964.57 | $2.6M | Form 4 |
| SING GEORGE L | director | Nov 2, 2026 | SELL | 7,073 | $965.38 | $6.8M | Form 4 |
| SING GEORGE L | director | Nov 2, 2026 | SELL | 1,522 | $966.27 | $1.5M | Form 4 |
| SING GEORGE L | director | Nov 2, 2026 | SELL | 1,040 | $967.07 | $1.0M | Form 4 |
| SING GEORGE L | director | Nov 2, 2026 | SELL | 200 | $970.18 | $194.0K | Form 4 |
| SING GEORGE L | director | Nov 2, 2026 | OPTION EX. | 7,830 | $376.69 | $2.9M | Form 4 |
| SING GEORGE L | director | Nov 2, 2026 | OPTION EX. | 7,439 | $380.95 | $2.8M | Form 4 |
| POON CHRISTINE A | director | Nov 2, 2026 | OPTION EX. | 7,830 | $376.69 | $2.9M | Form 4 |
| POON CHRISTINE A | director | Nov 2, 2026 | SELL | 218 | $966.74 | $210.7K | Form 4 |
| POON CHRISTINE A | director | Nov 2, 2026 | SELL | 772 | $967.38 | $746.8K | Form 4 |
| POON CHRISTINE A | director | Nov 2, 2026 | SELL | 2,499 | $968.58 | $2.4M | Form 4 |
| POON CHRISTINE A | director | Nov 2, 2026 | SELL | 3,203 | $969.50 | $3.1M | Form 4 |
| POON CHRISTINE A | director | Nov 2, 2026 | SELL | 937 | $970.51 | $909.4K | Form 4 |
| POON CHRISTINE A | director | Nov 2, 2026 | SELL | 201 | $971.31 | $195.2K | Form 4 |
| POON CHRISTINE A | director | Nov 2, 2026 | OPTION EX. | 7,830 | $376.69 | $2.9M | Form 4 |
| Fenimore Christopher R. | EVP Finance CFO | Nov 2, 2026 | OPTION EX. | 6,000 | $381.92 | $2.3M | Form 4 |
| Fenimore Christopher R. | EVP Finance CFO | Nov 2, 2026 | TAX W/H | 4,243 | $950.50 | $4.0M | Form 4 |
| Fenimore Christopher R. | EVP Finance CFO | Nov 2, 2026 | GIFT | 15 | — | — | Form 4 |
| Fenimore Christopher R. | EVP Finance CFO | Nov 2, 2026 | OPTION EX. | 6,000 | $381.92 | $2.3M | Form 4 |
| LAROSA JOSEPH J | EVP General Counsel and Secret | Nov 2, 2026 | OPTION EX. | 12,283 | $381.92 | $4.7M | Form 4 |
| LAROSA JOSEPH J | EVP General Counsel and Secret | Nov 2, 2026 | TAX W/H | 8,686 | $950.50 | $8.3M | Form 4 |
| LAROSA JOSEPH J | EVP General Counsel and Secret | Nov 2, 2026 | SELL | 3,939 | $965.41 | $3.8M | Form 4 |
| LAROSA JOSEPH J | EVP General Counsel and Secret | Nov 2, 2026 | SELL | 527 | $966.11 | $509.1K | Form 4 |
| LAROSA JOSEPH J | EVP General Counsel and Secret | Nov 2, 2026 | OPTION EX. | 12,283 | $381.92 | $4.7M | Form 4 |
| Guarini Kathryn | director | Oct 30, 2026 | OPTION EX. | 400 | $719.37 | $287.7K | Form 4 |
| Guarini Kathryn | director | Oct 30, 2026 | OPTION EX. | 400 | $719.37 | $287.7K | Form 4 |
| Guarini Kathryn | director | Oct 30, 2026 | SELL | 400 | $900.00 | $360.0K | Form 4 |
| BROWN MICHAEL S | director | Oct 30, 2026 | OPTION EX. | 1,929 | $725.89 | $1.4M | Form 4 |
| BROWN MICHAEL S | director | Oct 30, 2026 | SELL | 1,929 | $875.00 | $1.7M | Form 4 |
| BROWN MICHAEL S | director | Oct 30, 2026 | OPTION EX. | 1,929 | $725.89 | $1.4M | Form 4 |
| McCourt Marion | EVP Commercial | Oct 30, 2026 | SELL | 1,132 | $869.43 | $984.2K | Form 4 |
| MURPHY ANDREW J | Co-Chief Scientific Officer | Oct 13, 2026 | OPTION EX. | 17,000 | $381.92 | $6.5M | Form 4 |
| MURPHY ANDREW J | Co-Chief Scientific Officer | Oct 13, 2026 | TAX W/H | 12,853 | $754.58 | $9.7M | Form 4 |
| MURPHY ANDREW J | Co-Chief Scientific Officer | Oct 14, 2026 | SELL | 6 | $753.76 | $4.5K | Form 4 |
| MURPHY ANDREW J | Co-Chief Scientific Officer | Oct 14, 2026 | SELL | 35 | $755.91 | $26.5K | Form 4 |
| MURPHY ANDREW J | Co-Chief Scientific Officer | Oct 14, 2026 | SELL | 16 | $757.68 | $12.1K | Form 4 |
| MURPHY ANDREW J | Co-Chief Scientific Officer | Oct 14, 2026 | SELL | 24 | $758.16 | $18.2K | Form 4 |
| MURPHY ANDREW J | Co-Chief Scientific Officer | Oct 14, 2026 | SELL | 14 | $759.96 | $10.6K | Form 4 |
| MURPHY ANDREW J | Co-Chief Scientific Officer | Oct 14, 2026 | SELL | 74 | $760.65 | $56.3K | Form 4 |
| MURPHY ANDREW J | Co-Chief Scientific Officer | Oct 14, 2026 | SELL | 27 | $761.36 | $20.6K | Form 4 |
| MURPHY ANDREW J | Co-Chief Scientific Officer | Oct 14, 2026 | SELL | 55 | $762.57 | $41.9K | Form 4 |
| MURPHY ANDREW J | Co-Chief Scientific Officer | Oct 14, 2026 | SELL | 25 | $763.76 | $19.1K | Form 4 |
| MURPHY ANDREW J | Co-Chief Scientific Officer | Oct 14, 2026 | SELL | 219 | $764.40 | $167.4K | Form 4 |
| MURPHY ANDREW J | Co-Chief Scientific Officer | Oct 14, 2026 | SELL | 271 | $765.39 | $207.4K | Form 4 |
| MURPHY ANDREW J | Co-Chief Scientific Officer | Oct 14, 2026 | SELL | 279 | $766.47 | $213.8K | Form 4 |
| MURPHY ANDREW J | Co-Chief Scientific Officer | Oct 14, 2026 | SELL | 192 | $767.39 | $147.3K | Form 4 |
| MURPHY ANDREW J | Co-Chief Scientific Officer | Oct 14, 2026 | SELL | 105 | $768.33 | $80.7K | Form 4 |
| MURPHY ANDREW J | Co-Chief Scientific Officer | Oct 14, 2026 | SELL | 127 | $769.30 | $97.7K | Form 4 |
| MURPHY ANDREW J | Co-Chief Scientific Officer | Oct 14, 2026 | SELL | 12 | $770.20 | $9.2K | Form 4 |
| MURPHY ANDREW J | Co-Chief Scientific Officer | Oct 14, 2026 | SELL | 283 | $771.56 | $218.4K | Form 4 |
| MURPHY ANDREW J | Co-Chief Scientific Officer | Oct 14, 2026 | SELL | 211 | $772.56 | $163.0K | Form 4 |
| MURPHY ANDREW J | Co-Chief Scientific Officer | Oct 14, 2026 | SELL | 224 | $773.40 | $173.2K | Form 4 |
| MURPHY ANDREW J | Co-Chief Scientific Officer | Oct 14, 2026 | SELL | 121 | $774.48 | $93.7K | Form 4 |
| MURPHY ANDREW J | Co-Chief Scientific Officer | Oct 14, 2026 | SELL | 376 | $775.46 | $291.6K | Form 4 |
| MURPHY ANDREW J | Co-Chief Scientific Officer | Oct 14, 2026 | SELL | 66 | $776.31 | $51.2K | Form 4 |
| MURPHY ANDREW J | Co-Chief Scientific Officer | Oct 14, 2026 | SELL | 38 | $777.76 | $29.6K | Form 4 |
| MURPHY ANDREW J | Co-Chief Scientific Officer | Oct 14, 2026 | SELL | 454 | $778.64 | $353.5K | Form 4 |
| MURPHY ANDREW J | Co-Chief Scientific Officer | Oct 14, 2026 | SELL | 380 | $779.59 | $296.2K | Form 4 |
| MURPHY ANDREW J | Co-Chief Scientific Officer | Oct 14, 2026 | SELL | 463 | $780.63 | $361.4K | Form 4 |
| MURPHY ANDREW J | Co-Chief Scientific Officer | Oct 14, 2026 | SELL | 50 | $781.47 | $39.1K | Form 4 |
| MURPHY ANDREW J | Co-Chief Scientific Officer | Oct 13, 2026 | OPTION EX. | 17,000 | $381.92 | $6.5M | Form 4 |
| McCourt Marion | EVP Commercial | Sep 2, 2026 | SELL | 1,215 | $850.00 | $1.0M | Form 4 |
| McCourt Marion | EVP Commercial | Sep 3, 2026 | SELL | 1,131 | $857.39 | $969.7K | Form 4 |
| Guarini Kathryn | director | Sep 2, 2026 | OPTION EX. | 400 | $719.37 | $287.7K | Form 4 |
| Guarini Kathryn | director | Sep 2, 2026 | OPTION EX. | 400 | $719.37 | $287.7K | Form 4 |
| Guarini Kathryn | director | Sep 2, 2026 | SELL | 400 | $850.00 | $340.0K | Form 4 |
| LAROSA JOSEPH J | EVP General Counsel and Secret | Aug 19, 2026 | OPTION EX. | 12,282 | $381.92 | $4.7M | Form 4 |
| LAROSA JOSEPH J | EVP General Counsel and Secret | Aug 19, 2026 | TAX W/H | 9,019 | $830.15 | $7.5M | Form 4 |
| LAROSA JOSEPH J | EVP General Counsel and Secret | Aug 19, 2026 | OPTION EX. | 12,282 | $381.92 | $4.7M | Form 4 |
| Fenimore Christopher R. | EVP Finance CFO | Aug 18, 2026 | OPTION EX. | 6,283 | $381.92 | $2.4M | Form 4 |
| Fenimore Christopher R. | EVP Finance CFO | Aug 18, 2026 | TAX W/H | 4,599 | $813.47 | $3.7M | Form 4 |
| Fenimore Christopher R. | EVP Finance CFO | Aug 18, 2026 | OPTION EX. | 6,283 | $381.92 | $2.4M | Form 4 |
| Guarini Kathryn | director | Aug 10, 2026 | OPTION EX. | 400 | $719.37 | $287.7K | Form 4 |
| Guarini Kathryn | director | Aug 10, 2026 | OPTION EX. | 400 | $719.37 | $287.7K | Form 4 |
| Guarini Kathryn | director | Aug 10, 2026 | SELL | 400 | $800.00 | $320.0K | Form 4 |
Congress & Senate Trades (107)
Ro KhannaHouse · CA17Sep 4, 2026
Ro KhannaHouse · CA17Jul 7, 2026
Gilbert CisnerosHouse · CA31May 15, 2026
Ro KhannaHouse · CA17Apr 13, 2026
Alan ArmstrongSenateMar 27, 2026
Julia LetlowHouse · LA05Feb 12, 2026
Ro KhannaHouse · CA17Jan 29, 2026
Gilbert CisnerosHouse · CA31Nov 18, 2025
Ro KhannaHouse · CA17Sep 29, 2025
Ro KhannaHouse · CA17Aug 26, 2025
Robert P. BresnahanHouse · PA08May 15, 2025
Byron DonaldsHouse · FL19Apr 10, 2025
Byron DonaldsHouse · FL19Apr 10, 2025
Robert P. BresnahanHouse · PA08Apr 8, 2025
Jefferson ShreveHouse · IN06Apr 7, 2025
Julie JohnsonHouse · TX32Apr 1, 2025
Robert P. BresnahanHouse · PA08Feb 25, 2025
Julie JohnsonHouse · TX32Feb 12, 2025
Josh GottheimerHouse · NJ05Jan 24, 2025
Julie JohnsonHouse · TX32Jan 15, 2025
Josh GottheimerHouse · NJ05Nov 29, 2024
Josh GottheimerHouse · NJ05Nov 19, 2024
Jonathan JacksonHouse · IL01Nov 13, 2024
Jonathan JacksonHouse · IL01Nov 1, 2024
Josh GottheimerHouse · NJ05Oct 23, 2024
Greg LandsmanHouse · OH01Oct 15, 2024
Ro KhannaHouse · CA17Sep 9, 2024
Josh GottheimerHouse · NJ05Jul 1, 2024
Thomas Hawley TubervilleSenate · ALApr 4, 2024
Josh GottheimerHouse · NJ05Feb 8, 2024
Jonathan JacksonHouse · IL01Jan 17, 2024
Ro KhannaHouse · CA17Jan 10, 2024
Josh GottheimerHouse · NJ05Nov 13, 2023
Ro KhannaHouse · CA17Nov 3, 2023
Ro KhannaHouse · CA17Oct 2, 2023
Ro KhannaHouse · CA17Aug 29, 2023
Greg LandsmanHouse · OH01Aug 11, 2023
Ro KhannaHouse · CA17Aug 3, 2023
Ro KhannaHouse · CA17Jul 28, 2023
Josh GottheimerHouse · NJ05Jul 11, 2023
Ro KhannaHouse · CA17Jun 29, 2023
Ro KhannaHouse · CA17Jun 26, 2023
Jonathan JacksonHouse · IL01Jun 23, 2023
Josh GottheimerHouse · NJ05Jun 22, 2023
Ro KhannaHouse · CA17May 19, 2023
Ro KhannaHouse · CA17Apr 10, 2023
Thomas Hawley TubervilleSenate · ALApr 3, 2023
Thomas Hawley TubervilleSenate · ALApr 3, 2023
Ro KhannaHouse · CA17Mar 14, 2023
Josh GottheimerHouse · NJ05Mar 6, 2023